5 Treatment and prognostic factors in acute myeloid leukaemia-Reference-Cited by-同舟云学术

5 Treatment and prognostic factors in acute myeloid leukaemia

Published:1996-03 Issue:1 Volume:9 Page:87-105
ISSN:0950-3536
Container-title:Baillière's Clinical Haematology
language:en
Short-container-title:Baillière's Clinical Haematology

Author:

Rowe Jacob M.,Liesveld Jane L.

Publisher

Elsevier BV

Subject

Hematology

Reference103 articles.

1. Chemotherapy versus marrow transplantation for adults with acute nonlymphocytic leukemia: five year follow-up;Appelbaum;Blood,1988

2. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANNLL);Arlin;Leukemia,1990

3. Long term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group;Bennett;Leukemia Research,1991

4. Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myclogenous leukemia;Benyunes;Bone Marrow Transplantation,1993

5. Interleukin-2 bolus infusion as late consolidation therapy in 2nd remission of acute myeloblastic leukemia;Bergmann;Leukemia and Lymphoma,1995

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory clinical assessment of patients with AML over six years (2010-15) in Hematology -Oncology of Namazi Hospital in Shiraz;Journal of Fundamental and Applied Sciences;2016-09-01

2. Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol;International Journal of Hematology;2008-02-07

3. Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial;Blood;2006-07-01

4. High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience;Leukemia Research;2005-06

5. Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia;Leukemia Research;2004-01